A novel POU-domain protein, retina-derived POU-domain factor-l (RPF-I), has been identified through the isolation of cDNA and genomic DNA clones. In the adult, RPF-1 is expressed only within the CNS, where its expression is restricted to the medial habenulla, to a dispersed population of neurons in the dorsal hypothalamus, and to subsets of ganglion and amacrine cells in the retina. The human RPF-1 gene spans >I25 kb and gives rise to multiple differentially spliced transcripts.
The retina is an attractive region of the central nervous system in which to study questions of neuronal differentiation.
The vertebrate retina contains five major neuronal types: photoreceptor, bipolar, horizontal, amacrine, and ganglion cells. These are arranged in three layers, with photoreceptors in the outer layer; horizontal, bipolar, and amacrine cells in the central layer; and ganglion cells and displaced amacrine cells in the innermost layer (Rodieck, 1973; Dowling, 1987) . Information flows from the site of light absorption in the outer retina through a series of processing steps in the central and inner retina, ultimately to the ganglion cells from which the axons of the optic nerve arise. Each of the five major neuronal types listed above is divided further into subtypes. Classically, these neuronal subtypes have been characterized electrophysiologically, morphologically, and in the case of ganglion cells, by mapping the pattern of central projections. Although these approaches to classification were developed independently, they have become increasingly unified in recent years (Rodieck and Brening, 1983; Stone, 1983; Wassle and Boycott, 1991) .
Elucidating the molecular basis of neuronal diversity is one of the central challenges in understanding retinal organization. The approach described here involves the identification of novel transcriptional regulatory molecules, with the idea that neuronal di-
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Nov. I, 1995; rcviscd Dec. 28, 1995; accepted Jan. 4, 1996 versity reflects, at least in part, differences in genetic regulatory events. A number of transcription factors have been identified previously in the retina, including the homeodomain proteins Pax6 (Walther and Gruss, 1991) ChxlO (Liu et al., 1994) SOHo- (Deitcher et al., 1994) and 1~1-1 (Thor et al., 1991) . Each of these proteins is also found outside the retina. One basic region/leucine zipper gene, NRL, is expressed only in the retina, but probably plays a limited role in distinguishing cell types because it is expressed in all retinal cell layers (Swaroop et al., 1992) . The three members of the Brn-3 family of POU-domain genes may be important in generating retinal ganglion cell diversity on the basis of their expression in subsets of ganglion cells and their absence from other retinal cells (Gerrero et al., 1993; Xiang et al., 1993 Xiang et al., , 1995 Turner et al., 1994) . The Brn-3 factors are also expressed in subsets of neurons in the dorsal root and trigeminal ganglia and in a small number of midbrain nuclei.
Given the large number of distinct neuronal types within the retina and the diversity of their physiological and morphological propertics, it is reasonable to suppose that their development is controlled and coordinated by many as yet undiscovered transcriptional regulators. To identify such factors, we have focused on the POU-domain family. This family is defined by the presence of a bipartite DNA binding domain consisting of a POU-specific domain of -70 amino acids and a POU homeodomain of -60 amino acids, separated by a variable linker (Herr et al., 1988; Rosenfeld, 1991) . Several members of this family show highly restricted patterns of expression and are known to control cell type-specific differentiation pathways [e.g., Pit-l in the growth hormone-secreting cells of the anterior pituitary (Bodner et al., 1988; Ingraham et al., 1988; Li et al., 1991) ; Ott-2 in B-cells (Clerc et al., 1988; Scheidereit et al., 1988; Corcoran et al., 1993) ; and Uric-86 in various sensory neurons in the nematode Caenorhabditis eleguns (Chalfie et al., 1981; Finney et al., 1988) ]. In this paper we report the identification of a novel POU-domain factor, retina-derived POU-domain factor-l (RPF-l), which is expressed in subsets of retinal ganglion and amacrine cells. Because RPF-1 first appears at the time when the inner retina begins to form and is highly restricted in its pattern of expression, it is likely to play a role in the determination and/or differentiation of these neuronal types. Paxinos and Watson (1986) , Sidman et al. (1971), and Schambra et al. (1992) .
MATERIALS
For immunocytochemistry on wholemount retinas, the eye cup was fixed and cryoprotected in 30% sucrose, as described above. The retina was then gently dissected away from the choroid and sclera and frozen and thawed S-10 times in 2-methyl butane to aid the penetration of the antibodies.
The (5 FA, with a 7 set on/off duty cycle) during a period of 20-25 min. In one experiment, injections were made at each of several sites in both parvocellular and magnocellular layers, and, in a second experiment, at a single site in layer 6. After all injections were completed, the craniotomy was filled with dental cement, and the wound was closed with sutures. Two or 3 weeks later, the monkeys were anesthetized with ketamine and injected with a lethal dose of nembutal (100 mgikg, iv.). They were then perfused through the heart with 4 liters of 4% paraformaldehyde in 0. but including the 36 amino acid insert) fused to glutathione-S-transferase (GST) were constructed by PCR amplification of the corresponding cDNA sequences followed by cloning into the GST expression vector pGEX-2T (Pharmacia, Alameda, CA). All constructs described in this paper that were produced using PCR were sequenced to rule out PCR-induced mutations. Recombinant proteins were expressed in E. coli and purified by affinity chromatography on glutathione-agarose beads. For gel mobility shift experiments with a pure ohgonucleotide target, kinased double-stranded DNA (-0.1 ng) was incubated with between 1 and 150 ng of GST fusion protein in 15 ~1 of binding buffer [lo mM HEPES, pH 7.5, 50 mM KCl, 1 mM EDTA, 0.1% Triton X-100, 5% glycerol, 0.1 mM dithiothreitol ( and the resulting complexes were resolved on a 4% nondenaturing polyacrylamide gel 0.25~ Tris borate EDTA (TBE) buffer. Binding site selections (Thiesen and Bach, 1990) were performed essentially as described in Xiang et al. (1995) . In brief, for selection using the protein linked to glutathione beads, 100 ng of the double-stranded oligonucleotide target was mixed with 40 ng of GST fusion protein prebound to glutathione-agarose beads in 0.5 ml binding buffer [20 mM Tris-HCl, pH 8.0, 50 mM KCl, 0.5 mM EDTA, 1 mM DTT, 10% glycerol, 20 pg/ml bovine serum albumin, and 2 pg/ml poly-D(I-C)]. After incubation for 1 hr at 4°C with gentle rotation, the beads were washed twice in 1 ml of binding buffer without poly-D(I-C), resuspended in 30 ~1 water, and boiled for 2 min. Ten microliters of the eluted DNA was used as a template for 15 cycles of PCR, followed by one additional cycle containing a large excess of primer and Taq polymerase to ensure that the final products were double-stranded newly synthesized homoduplexes. After five rounds of enrichment and amplification, the PCR products were cloned into pBluescript, and individual clones were sequenced. For selection using preparative mobility shift gels, the radiolabeled target DNA was incubated with 50 ng of the GST fusion protein at room temperature for 20 min in 10 mM HEPES, pH 7.5, 50 mM KCl, 1 mM EDTA, 0.1 mM DTT, 0.1% Triton X-100, 5% glycerol, 50 pg/ml poly-D(I-C), and 0.1 mM PMSF. The complexes were resolved on a 4% native polyacrylamide gel in 0.25 X TBE, localized by autoradiography, excised, eluted in 300 ~1 of 0.5 M NH,OAc and 1 mM EDTA, and used as templates for the next round of PCR, as described above.
RESULTS
Identification and characterization of RPF-1 RPF-1 was identified initially by low-stringency hybridization to the POU domain of the human emb/Brn-5 gene (Anderson et al., 1993; Okamoto et al., 1993) . In this experiment, weakly hybridizing bands not accounted for by the emb/Brn-5 gene were observed in Southern blots of human, mouse, and chicken genomic DNA (Fig. 1) . Isolation and characterization of genomic clones containing the weakly hybridizing human and mouse fragments revealed the presence of a novel class VI POU-domain gene, RPF-1. To characterize the complete RPF-1 coding region, cDNA clones were isolated from a human retina cDNA library. Although these cDNA clones were found at a frequency of <l per lo5 recombinants, subsequent RNase protection and immunostaining experiments showed the retina to be the richest source of RPF-1 transcripts and protein. To characterize the intron/exon structure of the RPF-1 gene, clones encompassing each of the exons were isolated from bacteriophage A libraries prepared by using either human genomic DNA or DNA from two yeast strains that harbor overlapping human genomic segments as artificial chromosomes. A comparison of sequences from eight independent cDNA clones, 160 cloned 5' RACE-PCR products, and the exon and immediately adjacent intron regions of the cloned genomic segments shows that the RPF-1 gene is divided into at least 10 exons and is unusually large, encompassing >125 kb (Fig. 2) . Because the exact start sites of transcription have not been determined, the RPF-1 gene could have additional 5' noncoding exons. The cDNA and RACE-PCR sequence analysis reveals four positions at which alternate splicing generates distinct protein isoforms (Figs. 2,3) . In each case the sequence of the corresponding genomic DNA reveals a consensus splice junction at the predicted intronlexon boundary. The first alternative splice is found at the 5' end of the transcript, where one of four distinct first exons are spliced onto a unique second exon. The four alternate first exons would be predicted to generate three distinct amino-terminal sequences, if in each case the most 5' proximal in-frame ATG were used as the initiator methionine codon. The
Figure 2. Human RPF-1 genomic and cDNA clones. A, Restriction map of human genomic DNA. B, A genomic clones used to derive the genomic map. Several gaps in the map are indicated. The orientation of the second and fourth genomic phage groups with respect to the direction of transcription is unknown. C, cDNA clones isolated from the human retina contain either the consensus or the alternate POU-domain exon structure, as indicated to the r@zt by A or C, respectively. The cDNA clones define exons 2-10; the four alternate versions of exon 1, defined by RACE-PCR, are not shown and have not yet been mapped to genomic DNA. B, BarnHI; R, EcoRI; S, SalI.
second alternative splice results in the variable skipping of exon 6, which produces an in-frame insertion/deletion of 47 amino acids in a region of the protein upstream of the POU domain. The third alternative splice skips both exons 8 and 9, splicing exon 7 and to the 3' proximal splice acceptor in exon 10 (see below). The resulting open-reading frame is frameshifted at the exon 7-exon 10 splice junction, producing a truncated protein that lacks all POU-domain sequences. The fourth alternative splice occurs within the POU-specific domain in exon 10. The amino-terminal half of the POU-specific domain is encoded within exon 9 and is spliced to one of two alternate acceptor sites in exon 10. As shown in Figure 3 ,4,C, transcripts generated by splicing to the 3' proximal acceptor code for a POU domain that conforms well to the consensus POUdomain sequence (referred to hereafter as the "consensus" POU domain). As shown in Figure 3B , however, use of the 5 proximal splice acceptor in exon 10 generates a transcript that codes for a POU-specific domain with an in-frame insertion of 36 amino acids (referred to hereafter as the "alternate" POU domain). A comparison of the RPF-1 sequence and the Ott-l-DNA cocrystal structure shows that the insertion is in the center of the DNA recognition helix of the POU-specific domain (Figs. 3C, 4C ) (Klemm et al., 1994) . The 36 inserted amino acids have no apparent homology to other POU-domain sequences or to any sequences in the current GenBank database. That this alternate splicing event is of functional significance is suggested by its evolutionary conservation. A comparison of mouse and human RPF-1 exon 10 sequences reveals in both species the presence of the two splice-acceptor sequences and complete identity of the alternate exon at the nucleotide level (Fig. 3B) . Although some part of this sequence conservation may reflect constraints related to the control of differential splicing, complete identity at the amino acid level suggests that this polypeptide segment has a definite three-dimensional structure and biological function. A comparison of the complete human RPF-1 sequence and the sequences of other POU-domain factors indicates that RPF-1 represents a novel POU-domain gene. The closest homologs currently known are emb/Brn-5 (isolated from mouse and rat, respectively) (Anderson et al., 1993; Okamoto et al., 1993) and POU[C] (isolated from zebrafish) (Johansen et al., 1993) . This comparison suggests further that emb/Brn-5
and POU[C] are orthologs, consistent with the similar and widespread pattern of expression of each of these genes in the developing CNS.
Alternate and consensus POU domains
To investigate the biological significance of the 36 amino acid insertion within the POU-specific domain, we first asked whether transcripts encoding this alternate form constituted rare variants or whether they represented an appreciable fraction of RPF-1 transcripts. Reverse transcriptase (RT)-PCR analysis of human retina first-strand cDNA was performed by using one primer within exon 9 and a second primer within exon 10 that lies downstream of the two splice-acceptor sites (Fig. 4A,B) . Two distinct PCR products were obtained, and these conformed in size Figure 4 . Alternately spliced RPF-1 POU domains are present in human retina RNA. A, Top, Strategy for RT-PCR with one primer from exon 9 (encoding the amino-terminal half of the POU-specific domain) and a second primer from exon 10 (encoding the C-terminal half of the POU-specific domain and the POU homeodomain).
The structures of PCR products generated from mRNAs encoding the alternate and consensus POU domains are shown at the center and bottom, respectively.
Sequences encoding the 36 amino acid insert in the alternate POU domain are represented by a black region. B, Agarose gel electrophoresis of products obtained from the RT-PCR reaction diagrammed in A, using human retina first-strand cDNA as a template, shows bands at 310 and 200 bp; subcloning and sequencing of these products show that they arise from the use of alternate splice acceptors within the POU-specific domain as shown in Figure 3B . The 310 bp PCR product, which corresponds to the alternate POU domain, is found reproducibly in higher yield than the 200 bp product, which encodes the consensus POU domain. C, Predicted location within the POU-specific domain of the 36 amino acid insertion encoded by the alternate splice form of RPF-I. Fitting of the RPF-1 POU domain to the Ott-1 POU domain-DNA crystal structure (Klemm et al., 1994) shows that the insertion occurs in the middle of the recognition helix, as indicated by the avrowheud (see Fig. 3C for the primary sequence alignment with Ott-1).
The POU-specific domain is shown in blue and the POU homeodomain in red.
GST-Ott-1 GST-RPF-lalt GST-RPF-1 con and sequence to the two predicted splicing events. Interestingly, the larger of the two PCR products was reproducibly obtained in higher yield. We note that the ratio of the larger to the smaller PCR product should represent a lower estimate of the ratio of the corresponding transcripts, as the smaller of the two PCR products would be expected to amplify with an efficiency equal to or greater than that of the larger product.
To examine the functional effects of the 36 amino acid insertion, we studied the DNA binding properties of GST fusion proteins containing either the consensus or alternate RPF-1 POU domains. In one series of experiments, the RPF-1 POU-domain fusion proteins were immobilized on glutathione beads and used to enrich for target DNA molecules from a pool of synthetic double-stranded DNA segments in which a central core of 16 bases had been randomized. After five rounds of enrichment, the consensus and the alternate RPF-1 POU-domain-GST fusions had selected sequences containing (A/T)AAT and TAAT, respectively, the consensus expected if protein-DNA binding was mediated by the POU homeodomain. A parallel experiment using a GST fusion protein carrying the Ott-1 POU domain efficiently selected the consensus Ott-1 site ATGC(A/T)AAT. In a second series of experiments, preparative mobility shift gels were used as a more stringent enrichment method; in these experiments, the pool of synthetic double-stranded DNA segments had a central core of 24 randomized bases. Using this protocol, the consensus RPF-1 POU-domain-GST fusion again selected sequences containing (A/T&AT, whereas the alternate RPF-1 POU-domain-GST fusion failed to enrich for any subpopulation of sequences. These data indicate that the alternate POU-specific domain binds less tightly to its target(s). This difference in DNA binding affinity between the consensus and alternate splice forms of the RPF-1 POU domain is also apparent in comparing their binding to the Ott-1 consensus site ATGCAAAT (Fig. 5) . At all protein concentrations tested, the alternate POU domain failed to bind, whereas the consensus form bound with an efficiency approximately one tenth that of the Ott-1 POU domain. Although these experiments have failed to demonstrate high-affinity DNA binding by the alternate RPF-1 POU domain and have demonstrated DNA binding by the consensus RPF-1 POU domain that is of lower affinity and specificity than that of the Ott-1 POU domain, the possibility exists that interactions with other parts of RPF-1 or with other proteins could stabilize DNA protein complexes that are not seen with the purified POU-domain fusion proteins.
Developmental distribution of RPF-1 in the mouse The distributions of RPF-1 RNA and protein were determined in the adult mouse by RNase protection and by immunostaining with affinity-purified anti-RPF-1 antibodies. In the adult, RPF-1 transcripts are found only within the nervous system (Fig. 6) . Immunostaining of mouse brain, retina, spinal cord, and dorsal root ganglia shows that RPF-1 is present only in the medial habenula, in scattered cells in the hypothalamus, and in the retina, where it is found in subsets of cells in the ganglion cell layer and at the inner edge of the inner nuclear layer (Fig. 7) . As expected for a putative transcription factor, RPF-1 immunoreactivity is confined to nuclei. In the retina, a reproducible heterogeneity is seen in the intensity of immunostained cells. We note that the anti-RPF-1 antibodies do not cross-react with the most closely related POUdomain factor currently known, emb/Brnd, because they do not stain cerebral cortex where emb/Brnd is most abundant (Anderson et al., 1993; Okamoto et al., 1993) .
During development, RPF-1 is expressed most prominently in the retina. Staining is also seen in a small number of cells in the developing midbrain and in the spinal cord. In the mouse retina, the ganglion cell layer first forms in the central retina at approximately ell-e12, when the first postmitotic neurons migrate inward from the adjacent zone of proliferating neuroblasts. RPF-1 immunoreactivity is first observed at ell in the future ganglion cell layer in the central retina, and as development proceeds, RPF-l-expressing cells accumulate in the inner retina (Fig. 8) . 
RPF-1 in subsets of amacrine and ganglion cells
To identify more precisely the retinal cells expressing RPF-1, immunostaining experiments were carried out in the cat and monkey, species in which morphometric, anatomic, and physiological studies have defined many of the retinal cell types. In the cat retina, ganglion cells have been divided into three groups, GE, /3, and y, which have large, medium, and small soma sizes, respectively (Boycott and Wassle, 1974) and these correspond to the physiologically defined Y, X, and W groups (Cleland et al., 1975; Saito, 1983; Fukuda et al., 1985) . Amacrine cells in the cat retina, as in other mammalian retinas, constitute an extremely heterogeneous group of cells, with cell bodies in both the inner part of the inner nuclear layer and in the ganglion cell layer. To facilitate a quantitative analysis of RPF-l-expressing cells, flatmounts of cat retinae were triple-stained with anti-RPF-1 [visualized with horseradish peroxidase (HRP)], AB.5, a monoclonal antibody previously shown to stain ganglion cells (Fry et al., 1985) (visualized with fluorescein), and 4'6-diamidino-2-phenylindole (DAPI) (Fig.  9) . Within the ganglion cell layer, RPF-1 is present in 50-60% of the cells, and this staining was confined to nuclei, as in the mouse retina. If we assume that AB5 stains all ganglion cells in the cat retina, then approximately half of the RPF-l-stained cells are ganglion cells; the remainder are presumed to be displaced amacrine cells. Among ganglion cells, the RPF-l-staining intensity varied widely. A fraction of small-and medium-sized cells stained most strongly, whereas the large (a) cells stained weakly or not at all. Within the inner nuclear layer, RPF-1 staining was found only in the innnermost layer of cells, indicating that these are amacrine cells. We conclude from this analysis that in the cat retina, RPF-1 is expressed in many /3 and y ganglion cells and in a subset of amacrine cells.
In the monkey retina (Rodieck, 1988) , -80% of ganglion cells project to the parvocellular layers of the LGN, have small cell bodies, and carry color opponent signals (P-cells). An additional 10% of ganglion cells project to the magnocellular layers of the LGN, have large cell bodies, and carry luminance signals (Mcells). The remaining 10% of ganglion cells comprise a number of physiologically and morphologically distinct types that project to targets other than the LGN, principally the tectum (superior colliculus) and pretectum. In the primate retina, ganglion cell density decreases -loo-fold from center to periphery. Because the density of displaced amacrine cells decreases less steeply, the ratio of amacrine to ganglion cells increases with eccentricity, from -1:20 in the center to -1:l in the periphery (Wassle et al., 1989) .
In cross-sections of the macaque retina, the RPF-1 immunostaining pattern resembles that seen in mouse retinae, except that the amacrine cells in the inner nuclear layer are stained more strongly in the macaque (Fig. 10A,B) . Immunostaining of flatmounts of macaque retina shows a small population of cells that stain intensely for RPF-1, and a large population that stains at either weak or intermediate levels. The numerical density of the most strongly stained cells varies little with eccentricity, whereas the density of the less strongly stained cells falls rapidly with eccentricity ( Fig. lOC-E) . To characterize further the identities of the RPF-l-expressing cells, we immunostained retinae that were retrogradely labeled from the LGN by iontophoretic injection of Texas red-conjugated or fluorescein-conjugated dextran. Injection into both the magno-and parvocellular layers of the LGN revealed many hundreds of backfilled ganglion cells, including both large and small types, all of which stained at either weak or intermediate intensity with anti-RPF-1 antibodies (Fig. 11) . These data indicate that P-and M-type ganglion cells contain low to intermediate levels of RPF-1. The data do not rule out the possibility that other less abundant ganglion or amacrine cell types also contain these levels of RPF-1. The strongly immunostained cells could represent either displaced amacrine cells or an unusual population of ganglion cells. DISCUSSION RPF-1, a complex PO&domain gene This paper describes the identification of a new POU-domain gene, RPF-1. The structure of the RPF-1 transcription unit is unusual in its length, at least 125 kb, and in the complexity of differential splicing inferred from the structure of cDNA clones and RT-PCR products. Alternate exon structures are observed at four locations within the transcription unit. Any one of four exons is present at the 5' end of the coding region, possibly representing the use of alternate promotors; exon 6 is variably present, producing an in-frame insertion or deletion of 47 amino acids outside the DNA binding domain; exons 8 and 9 are variably present, generating a prematurely truncated protein lacking the POU domain; and exon 10 is present in either of two forms that differ in the choice of splice acceptors, thereby creating a consensus POU domain or an alternate POU domain in which the DNA recognition helix of the POU-specific domain is interrupted by an in-frame insertion of 36 amino acids (Figs. 3, 4) . If each of the observed differential splicing events can occur independently, then the RPF-1 gene has the potential to generate 24 different proteins. The 24 isoforms can be divided into six major classes that differ internally by the presence or absence of alternate coding sequences.
Although the functional effects of differential splicing of exons 1 and 6 remain to be determined, generation of transcripts lacking a POU domain or encoding the alternate POU domain would be predicted to dramatically impair the DNA binding properties of the resulting protein. In vitro experiments with POU domains produced as GST fusion proteins confirm this prediction with respect to the alternate POU domain. In gel mobility shift assays, the consensus RPF-1 POU domain bound with moderate affinity to an Ott-1 site, whereas the alternate POU domain failed to bind. A similar difference in affinity was observed during in vitro selection of DNA binding sites. The simplest interpretation of these data are that the 36 amino acid insertion in the DNA recognition helix of the POU-specific domain sterically disrupts protein-DNA binding. We also observed in these experiments that the consensus RPF-1 POU domain bound to its selected DNA targets with lower affinity and specificity than did a control Ott-1 POU domain, suggesting that the RPF-1 POU domain may require additional protein-protein interactions to bind tightly to DNA.
If the insertion within the POU-specific domain functioned only to disrupt protein-DNA contacts, we would expect its sequence to drift over time, although this drift might be constrained by the nucleotide sequence requirements for differential splicing. Surprisingly, a comparison of human and mouse RPF-1 sequences shows that this region has remained identical for 200 million years, at both the nucleotide and amino acid levels. This identity indicates an important functional role for the alternate POU domain and suggests the possibility that the inserted polypeptide adopts a definite three-dimensional structure. It is tempting to speculate further that RPF-1 isoforms that carry the alternate POU domain may interact with other cellular proteins and that these protein-protein interactions involve the 36 amino acid insertion.
Implications for retinal diversity and development
Analysis of the time and tissue distribution of RPF-1 transcripts and protein reveals a remarkably specific pattern. Among major organs in the adult mouse, only the CNS contains RPF-1 transcripts, and within the CNS, RPF-1 expression is confined to the medial habenulla, to a dispersed population of neurons in the dorsal hypothalamus, and to subsets of amacrine and ganglion cells in the retina. Within the retinas of mice, cats, and monkeys, a consistent pattern of RPF-1 immunostaining is seen. In each species it is found in nuclei at the inner edge of the inner nuclear layer; these are presumed to be the nuclei of amacrine cells. Within the ganglion cell layer, RPF-1 seems to be expressed in most ganglion cells and in displaced amacrine cells, as determined by backfilling of ganglion cells from the LGN in the monkey and by immunostaining with a ganglion cell-specific antibody (AB.5) in the cat. As noted previously for ganglion cell staining by antibodies to the Brn-3 family of POU-domain factors, the intensity of RPF-1 immunostaining varies among cells in a manner that is characteristic for each species (Xiang et al., 1993 (Xiang et al., , 1995 .
In the macaque retina, most of the P-and M-type ganglion cells have a low to intermediate level of RPF-1. The subset of cells within the ganglion cell layer that stain most intensely for RPF-1 are neither P-nor M-type ganglion cells, because they are not backfilled from the LGN and show little change in density with increasing eccentricity. They may represent either a group of displaced amacrine cells or an unusual population of ganglion cells. In the cat retina, almost all of the /3 and y ganglion cells express RPF-1, and these RPF-l-expressing cells account for -90% of the ganglion cells. The cy cells, which account for -5% of ganglion cells, stain weakly or not at all for RPF-1.
In the developing mouse CNS, RPF-1 immunostaining is most prominent within the retina where it first appears at day ell within the developing ganglion cell layer. In the mouse, ["Hlthymidine-labeling studies have shown that most ganglion cell precursors become postmitotic between ell and e18, and amacrine cell precursors become postmitotic between e13 and e18 (Sidman, 1961) . These newly postmitotic cells migrate inward from the dividing neuroblast layer to reach their final destinations within the developing retina, a pattern analogous to that observed for the generation of cerebral cortical neurons from the ventricular zone. In the developing chicken retina, immunostaining with a ganglion cell-specific monoclonal antibody demonstrates that ganglion cells begin to differentiate shortly after their terminal mitosis and while they are still migrating (McLoon and Barnes, 1989; Wald and McLoon, 1995) . The appearance of RPF-1 at the earliest stages of retinal differentiation and its presence in recently postmitotic cells suggest that RPF-1 is involved in early steps of ganglion and amacrine cell commitment.
This inference is supported by experiments with Brn-3b, a POU-domain factor that in the adult retina is expressed only in ganglion cells. In the developing retina, the timing of Brn-3b expression resembles that of RPF-1, and recent experiments show that mice that are homozygous for a targeted disruption of the Brn-3b gene have 70% fewer ganglion cells (L. Gan, M. Xiang, L. Zhou, D. S. Wagner, W. H. Klein, and J. Nathans, unpublished observations). Targeted disruption of the RPF-1 gene should similarly clarify the role of this gene in ganglion and amacrine cell development.
